+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Age: 18Years - 65Years
All Genders
ID07045467

Study of Remimazolam Continuous Infusion for Sedation in Adults Undergoing Kidney Transplant Surgery

Led by Qianfoshan Hospital · Updated on 2025-10-01

30

Participants Needed

1

Research Sites

47 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying the pharmacokinetics how the drug moves through the body and pharmacodynamics how the drug affects the body of remimazolam in adults undergoing kidney transplant surgery. This trial focuses on understanding key drug parameters such as peak concentration, time to peak, area under the curve, and elimination half-life. It also measures the drugs impact on consciousness using the MOAAS sedation scale and Narcotrend monitoring during anesthesia. Participants will receive continuous intravenous infusion of remimazolam besylate following a specific anesthesia protocol for renal transplant surgery. The induction dose is 6 mgkgh until loss of consciousness, followed by a maintenance dose titrated between 0.5 and 2 mgkgh to maintain the target anesthesia depth. Additional medications like analgesics, muscle relaxants, and immunosuppressants are given according to protocol, while common sedatives such as midazolam and propofol are avoided. During the study, participants will have blood samples collected at multiple time points before, during, and after infusion to analyze drug levels and metabolism. Sedation depth will be regularly assessed using MOAAS and continuous Narcotrend monitoring. Safety evaluations include lab tests, vital signs, and physical exams. Researchers will track various outcomes such as urine output, kidney function, and possible adverse events through the surgery and up to six days post-operation.

CONDITIONS

Brief Title

Remimazolam Infusion in Kidney Transplant Patients: A Multicenter Study

Research Team

G

guanghan wu

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here